日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease

精准医学分析早期阿尔茨海默病中个体对β-淀粉样蛋白清除治疗反应的异质性

Pang, Menglan; Gabelle, Audrey; Saha-Chaudhuri, Paramita; Huijbers, Willem; Gafson, Arie; Matthews, Paul M; Tian, Lu; Rubino, Ivana; Hughes, Richard; de Moor, Carl; Belachew, Shibeshih; Shen, Changyu

New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis

关于多发性硬化症中退行性变和自身免疫之间复杂相互作用的新观点

Stys, Peter K; Tsutsui, Shigeki; Gafson, Arie R; 't Hart, Bert A; Belachew, Shibeshih; Geurts, Jeroen J G

Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis

适应性免疫和先天性免疫是多发性硬化症发病年龄的关键驱动因素

Misicka, Elina; Huang, Yunfeng; Loomis, Stephanie; Sadhu, Nilanjana; Fisher, Elizabeth; Gafson, Arie; Runz, Heiko; Tsai, Ellen; Jia, Xiaoming; Herman, Ann; Bronson, Paola G; Bhangale, Tushar; Briggs, Farren B

Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis

多发性硬化症中顺磁性环和缓慢扩展病灶的病灶水平对应性和纵向特性

Elliott, Colm; Rudko, David A; Arnold, Douglas L; Fetco, Dumitru; Elkady, Ahmed M; Araujo, David; Zhu, Bing; Gafson, Arie; Tian, Zhe; Belachew, Shibeshih; Bradley, Daniel P; Fisher, Elizabeth

Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation

胶质纤维酸性蛋白与多发性硬化症的进展独立于急性炎症

Jiang, Xiaotong; Shen, Changyu; Teunissen, Charlotte E; Wessels, Mark; Zetterberg, Henrik; Giovannoni, Gavin; Singh, Carol M; Caba, Bastien; Elliott, Colm; Fisher, Elizabeth; de Moor, Carl; Belachew, Shibeshih; Gafson, Arie R

Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials

一项涵盖六项临床试验的多发性硬化症进展纵向脑成像指标的全基因组研究

Loomis, Stephanie J; Sadhu, Nilanjana; Fisher, Elizabeth; Gafson, Arie R; Huang, Yunfeng; Yang, Chengran; Hughes, Emily E; Marshall, Eric; Herman, Ann; John, Sally; Runz, Heiko; Jia, Xiaoming; Bhangale, Tushar; Bronson, Paola G

Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation

血清神经丝轻链与多发性硬化症进展无关,与急性炎症无关

Gafson, Arie R; Jiang, Xiaotong; Shen, Changyu; Kapoor, Raj; Zetterberg, Henrik; Fox, Robert J; Belachew, Shibeshih

Chronic lesion activity and disability progression in secondary progressive multiple sclerosis

继发性进展型多发性硬化症的慢性病变活动和残疾进展

Beynon, Vanessa; George, Ilena C; Elliott, Colm; Arnold, Douglas L; Ke, Jun; Chen, Huaihou; Zhu, Li; Ke, Chunlei; Giovannoni, Gavin; Scaramozza, Matthew; Campbell, Nolan; Bradley, Daniel P; Franchimont, Nathalie; Gafson, Arie; Belachew, Shibeshih

Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study

LIBERATE 研究结果:多发性硬化症患者在常规临床实践中使用缓释法莫吡啶治疗的安全性、患者自述健康状况和医生评估的步行能力

Castelnovo, Giovanni; Gerlach, Oliver; Freedman, Mark S; Bergmann, Arnfin; Sinay, Vladimiro; Castillo-Triviño, Tamara; Kong, George; Koster, Thijs; Williams, Heather; Gafson, Arie R; Killestein, Joep

A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis

一项关于纳他珠单抗治疗复发缓解型多发性硬化症的随机研究

Trojano, Maria; Ramió-Torrentà, Lluís; Grimaldi, Luigi Me; Lubetzki, Catherine; Schippling, Sven; Evans, Karleyton C; Ren, Zheng; Muralidharan, Kumar Kandadi; Licata, Stephanie; Gafson, Arie R